Identification of a SCN5A Genetic Variant Associated With Type 1 Brugada Syndrome (BrS) in a Family

Jack Jnani1, Dorota Gruber2, Tafadzwa Mtisi3

  • 1Internal Medicine, North Shore University Hospital, Manhasset, USA.

Cureus
|August 19, 2024
PubMed

Insights

Brugada pattern, a genetic disorder, increases sudden cardiac death risk. A SCN5A gene variant, initially uncertain, was reclassified as pathogenic due to family history and clinical context.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Brugada pattern is an EKG finding linked to genetic disorders and increased risk of sudden cardiac death.
  • SCN5A gene mutations, encoding cardiac sodium channels, are associated with Brugada syndrome (BrS).

Observation:

  • A patient presented with spontaneous type 1 Brugada pattern on routine EKG.
  • Electrophysiological testing provoked ventricular tachycardia, leading to implantable cardioverter defibrillator placement.
  • Family history included sudden cardiac death, syncope, and diagnosed BrS.

Findings:

  • Genetic testing identified a SCN5A variant of uncertain significance (VUS) in the patient and six relatives.
  • The VUS, in conjunction with clinical presentation and family segregation, supports reclassification to pathogenic.
  • This highlights the importance of genetic analysis in diagnosing Brugada syndrome.

Implications:

  • Reclassifying the SCN5A VUS as pathogenic aids in diagnosing BrS in affected families.
  • This case underscores the clinical utility of genetic testing and family history in identifying arrhythmia risks.
  • Understanding SCN5A variants is crucial for risk stratification and management of patients with Brugada pattern.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.2K
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
22.2K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genetic Lingo01:11

Genetic Lingo

Overview
102.3K